Business Overview - The company operates primarily in two segments: automotive parts and automotive sales and services [2][3] - The automotive parts segment focuses on crankshaft products for various domestic and international manufacturers, leading in production and sales in the domestic passenger vehicle crankshaft industry [3] - The automotive sales segment includes brands such as SAIC Volkswagen, FAW Volkswagen, and new energy brands like Xiaomi and Avita [2][3] Financial Performance - In 2024, the company reported revenue of CNY 3.595 billion, a decrease of 6.73% year-on-year, with a net loss of CNY 20.057 million, improving by 84.05% compared to the previous year [3] - The crankshaft production reached 2.549 million units in 2024, a year-on-year increase of 43.89%, while sales were 2.531 million units, up 40.84% [3] - For the first three quarters of 2025, revenue was CNY 2.183 billion, down 16.98%, but net profit increased by 279.04% to CNY 42.775 million [3] Product and Market Strategy - The company’s crankshaft products have a gross margin of 23.47% in 2024 and 21.94% in the first half of 2025 [4] - The product layout follows a "361" strategy: 30% from traditional fuel vehicle crankshafts, 60% from new energy vehicle crankshafts, and 10% from other new automotive parts [5] - Plans for a new production line for new energy vehicle crankshafts with an investment of CNY 200 million to produce 600,000 units annually [8] Customer and Revenue Sources - Major clients include Chery, Li Auto, BYD, and others in the automotive sector [4] - The automotive sales segment profits mainly from dealer rebates and after-sales services [6] Future Directions - The company aims to enhance its presence in the new energy vehicle sector and precision manufacturing [8] - Adjustments in the automotive sales strategy include optimizing brand structure and improving operational efficiency through a main store + satellite store model [8] Shareholder Information - The controlling shareholder, Tianjin Rongcheng Material Group, has no current plans to inject assets into the listed company [9]

Financial Performance - In the first three quarters of 2025, the company achieved a net profit of approximately 54.65 million yuan, with the pig farming segment contributing about 61.5 million yuan in profit, while the poultry segment incurred a loss of 7 million yuan and the waterfowl segment a loss of approximately 2 million yuan [2][4] - In Q3 2025, the net profit was reported at 19.15 million yuan, with the pig farming segment generating a profit of 15 million yuan, and the poultry segment reaching a breakeven point [2][4] Production and Sales - The company sold a total of 2,767,249 pigs (including live pigs, fresh products, and piglets) and 9.45 billion chickens (including live chickens, fresh products, and cooked food) in the first three quarters [2][4] - The sales of piglets are expected to reach approximately 2 million heads in Q4 2025 due to established external sales channels [3] Cost Management - The production cost for piglets in Q3 2025 decreased to around 260 yuan per head, with a meat pig comprehensive breeding cost of 6.2 yuan per jin [5][6] - The comprehensive cost for meat chickens was reported at 5.8 yuan per jin, influenced by rising feed prices [7] Risk Mitigation Strategies - The company maintained a debt ratio of 49.4% by the end of Q3 2025, focusing on stable operations and reducing financial risks [9] - Despite facing temporary losses in the pig farming sector, the poultry segment performed well, providing a buffer against market risks [9] Shareholder Returns - The company distributed a cash dividend of 3 yuan per 10 shares, totaling 19.9 billion yuan, which accounts for 38% of the net profit attributable to shareholders in the first three quarters [11] - A stock buyback program is in place, with a total of 900 million yuan allocated for repurchase from September 2024 to September 2025 [12] Strategic Initiatives - The company is focusing on high-quality growth, aiming to enhance its breeding capabilities and optimize its product structure, with a target for piglet sales to account for 5%-10% of total pig sales [16][17] - Plans to expand into international markets are underway, prioritizing the export of poultry products, followed by pork and duck products [21] Brand Development - The company is launching new brands, including "Wens Food," "Wens Livestock," and "Wens Ingredients," to better segment its product offerings [14] - Efforts to promote the cultural significance of Chinese native chickens are ongoing, including partnerships and events to enhance market understanding [13]

证券代码：301319 证券简称：唯特偶 投资者关系 活动类别 ☑ 特定对象调研 □ 分析师会议 □ 媒体采访 □ 业绩沟通会（电话会） □ 新闻发布会 □ 路演活动 □ 现场参观 □ 其他 参与单位名称及 人员名称 国泰海通 汪义芬、刘环环、陈惠华；荣炜基金 汪敬波；诺信达 基金 钟建波；圆石投资 刘伟；合心资本 周沛盛、鲁正轩；深 圳瑞皖科技 熊洪图；飞扬鹏城控股 周旭辉；潮商投资 张镇江； 六屏基金 王超。 时间 2025 年 11 月 03 日 14:30-16:30 地点 公司会议室 上市公司 接待人员姓名 投资部总经理：钟科先生 证券事务代表：潘露璐女士 证券事务专员：吴锋威先生 投资者关系活动 主要内容介绍 1、请问公司在低银无铅焊料、高温胶粘剂等关键产品上，是 否具备独家配方或工艺？ 答：在产品配方方面，公司掌握了免冷藏锡膏技术、超细粉锡 膏技术、零卤锡膏技术、少空洞锡膏技术、低温锡膏技术、水基 清洗剂技术、光伏组件助焊剂技术、免清洗助焊剂技术、水基助 焊剂技术等多项核心配方技术；在工艺制程方面，公司取得了一 些关键生产工艺技术的突破，主要涵盖助焊膏体研磨技术、自动 化真空膏体搅拌技术、超细焊 ...

Group 1: Company Overview - The company is Hangzhou Baicheng Pharmaceutical Technology Co., Ltd., with stock code 301096 and abbreviation Baicheng Pharmaceutical [1] Group 2: Subsidiary Progress - Subsidiary Simmer Pharmaceutical has a construction area of approximately 260 acres, with 163,000 square meters of GMP-standard facilities [2] - Simmer has completed 617 project verifications and registered 461 projects, ranking among the top in the country [2] - In the 11th batch of national drug centralized procurement, Simmer is expected to win bids for 12 products, enhancing its production capacity and market share [2] Group 3: Collaborations - The company collaborates closely with the Hangzhou Institute of Advanced Studies at the University of Science and Technology of China, establishing a joint R&D center since 2022 [3] - The joint laboratory has been recognized as a key laboratory in Zhejiang Province for 2024, focusing on innovative drug development in various fields [3] Group 4: Core Technology Platforms - The company has three main technology platforms: innovative drug R&D center, high-end complex formulation platform, and traditional Chinese medicine and natural drug R&D center [3] - Over 15 new drug pipelines have been established, covering areas such as neurobiology, autoimmune diseases, and oncology [3] Group 5: Innovative Drug Development - The company is advancing over 15 self-developed new drug pipelines, including drugs for OSA-related daytime sleepiness, autoimmune inflammation, and tumors [3] - The drug Bios-0618 for OSA is currently in the clinical phase II enrollment stage, while Bios-0625 for autoimmune inflammation is in the IND application stage [3] - The company has obtained 3 IND approvals for its first-class new drug and is actively pursuing overseas collaborations to enhance growth potential [3]

Group 1: Business Performance and Strategy - The company is focused on a strategic shift from "scale first" to "quality first," resulting in improved profitability and a clear path for value creation [3][4] - Despite challenges in the external environment, the company has optimized its product structure and customer mix, particularly in the AI sector, leading to a gradual recovery in profitability [2][3] - The company has established deep partnerships with leading global AI brands, which are expected to drive revenue growth through new technology mass production projects in 2026 [3][4] Group 2: Financial Metrics and Growth Drivers - The company reported a positive trend in financial indicators for the first three quarters of the year, indicating a shift towards quality improvement [2] - The storage business has achieved profitability, contributing to a second growth curve for the company [3][7] - The company anticipates further enhancement of overall profitability as the proportion of high-end AI products increases and the scale effects from its manufacturing bases are realized [3][4] Group 3: Product Development and Innovation - Continuous investment in innovative technologies such as solid-state, high-silicon, and sodium batteries ensures the company maintains a competitive edge and avoids price competition [4][5] - The company is actively developing energy solutions for data centers, having made significant breakthroughs in backup battery systems [8][9] - The company is positioned to meet the growing demand for AI-related products, including AI glasses and toys, which are expected to become market leaders [9][10] Group 4: Market Challenges and Responses - The company has implemented a three-pronged strategy to address rising raw material costs, including short-term pricing adjustments, mid-term product upgrades, and long-term technological advantages [5][6] - The company is focused on optimizing its product structure towards high-value, high-margin products to navigate through market cycles [5][6] - The storage market is viewed as a long-term opportunity, with the company leveraging its expertise in battery safety technology to build a competitive advantage [7][8] Group 5: Competitive Advantages - The company has built a robust competitive advantage through long-term relationships with major global brands, underpinned by a commitment to safety, quality, delivery, and cost (SQDC) [11][12] - The company’s forward-looking technology layout and product definition capabilities allow it to meet current market demands while ensuring sustainable competitive advantages [11][12] - Lean manufacturing capabilities and the successful operation of its production bases provide resilience against complex international trade environments [12]

Group 1: Strategic Adjustments - The company has introduced new talent in key online and mid-platform positions, focusing on core products and optimizing business structure to enhance product competitiveness and channel penetration [1] - Systematic improvements in profitability, technological accumulation, and brand layout have been achieved through ongoing strategic adjustments [1] Group 2: Research and Development - R&D expenses decreased by 14.17% year-on-year, attributed to normal fluctuations in project progress, with a commitment to maintaining high levels of R&D investment [1] - The company is leveraging its Yunnan Province plant extraction laboratory and global R&D centers to conduct comprehensive research projects from basic research to product development [2] Group 3: Financial Performance - Operating cash flow reached 442 million yuan in the first three quarters, a remarkable increase of 6772.14%, indicating strong cash generation capability and operational efficiency [2] - The company has implemented proactive inventory and channel management strategies, laying a solid foundation for long-term value growth [2] Group 4: Intangible Assets - Intangible assets increased significantly by 116%, primarily due to the acquisition of trademarks, patents, and non-patent technologies related to the TriPollar brand [2] - The acquisition strengthens the company's R&D and technological moat, marking its entry into the billion-level beauty instrument market and opening a second growth line [2]

Group 1: Financial Performance - The company's Q3 2025 profit growth was below expectations due to changes in product structure, higher overseas production costs, and increased R&D, sales, and share-based payment expenses [3] - The overall R&D expense ratio is expected to slightly decrease next year as revenue grows, while maintaining a high level of investment to sustain competitive advantages [1] Group 2: Automotive Electronics - The automotive electronics sector is facing intensified competition, impacting profitability; the company is enhancing its market competitiveness through technical barriers and product innovation [2] - New products like the electric flip screen have been adopted by multiple automotive clients, and the company is expanding its global footprint, particularly in North America and Europe [2] Group 3: Health Environment Business - The health environment business experienced rapid growth in Q3 2025, driven by successful mass production of key projects; the company is deepening collaborations and expanding product lines [2] - The company is optimistic about the future development of the health environment sector [2] Group 4: E-bike Products - E-bike product revenue saw a slight decline in Q3, but overall, it has shown year-on-year growth; the long-term outlook remains positive due to market trends favoring eco-friendly products [3] - The company has achieved recognition as one of the top suppliers globally, receiving the "2023/2024 Global Supplier Award" from a major client, which enhances its competitive position [4]

Financial Performance - The total revenue for the year-to-date period reached 364.7 billion CNY, representing a year-on-year growth of approximately 14% [2] - The net profit attributable to the parent company was 37.9 billion CNY, with a growth rate of 20% [2] - The revenue from the three major ToB segments is as follows: - New Energy and Industrial Technology: 30.6 billion CNY, a year-on-year increase of 21% [3] - Smart Building Technology: 28.1 billion CNY, a year-on-year increase of 25% [3] - Robotics and Automation: 22.6 billion CNY, a year-on-year increase of 9% [3] Energy Storage and AI Strategy - The company launched its energy strategy focusing on "Energy Storage + Heat Pump + AI" [3] - The new Aqua-C3.0 Pro liquid cooling energy storage system was unveiled, reducing total ownership costs by 10.63% [3] - The ultra-high temperature industrial heat pump can achieve 130°C, with a COP of up to 4.2, promoting energy savings [3] - The Energy+ platform has integrated over 1.5 GW of distributed photovoltaic systems, achieving a price forecast accuracy of 92% and load prediction accuracy of 97% [3] Robotics Development - The company introduced a robotics strategy focusing on AI + Robotics, humanoid robot development, and core components [4] - At the 2025 Shanghai Industrial Expo, KUKA showcased five strategic intelligent products, marking a new phase in intelligent manufacturing [4] - The humanoid robot "Mei Luo" is now operational in the company's washing machine factory, performing various tasks [5] - The core components for robotics, such as harmonic reducers, have a production capacity of 80,000 units by the end of 2024 [5] Supply Chain and Commodity Price Management - The company operates in over 200 countries and regions, with 22 R&D centers and major manufacturing bases in more than ten countries [5] - To mitigate the impact of commodity price fluctuations, the company is enhancing product structure, optimizing supply chain management, and implementing bulk purchasing strategies [5] - Copper prices increased by approximately 40% year-on-year, but the company's net profit margin has rebounded since 2022 [5] - The company aims to deepen DTC reforms to achieve cost reduction and efficiency improvement [5]

Group 1: Financial Performance - In the first three quarters of 2025, the company achieved operating revenue of 6.548 billion CNY, a year-on-year increase of 5.39% [3] - Total profit reached 2.172 billion CNY, up 11.31% year-on-year [3] - Net profit attributable to shareholders was 1.764 billion CNY, reflecting a growth of 8.49% [3] - As of September 2025, total assets amounted to 49.371 billion CNY, a 1.90% increase from the end of the previous year [3] - Net assets attributable to shareholders grew to 19.482 billion CNY, up 7.28% from the previous year [3] Group 2: Factors Influencing Performance - Revenue and profit growth were primarily driven by increased business volume in water supply and drainage, adjustments in sewage treatment fees, and improved credit recovery in certain regions [3] - New operational projects, such as the Chengdu Washaway Reclaimed Water Plant and the third phase of the First City Sewage Sludge Treatment Plant, contributed to additional capacity [3] Group 3: Profitability Metrics - The gross margin for the main business was 47.90%, an increase from 44.76% in the same period last year [3] - Factors contributing to the improved gross margin included increased water sales and a reduction in costs due to changes in tax accounting [3] Group 4: Project Updates - The second phase of the Chengdu Sixth Reclaimed Water Plant and the second phase of the Eighth Reclaimed Water Plant are currently in the commissioning stage, with expected operation next year [4] Group 5: Accounts Receivable Management - The company has prioritized accounts receivable management, forming a dedicated team to enhance collection efforts, resulting in stable overall collection rates compared to the previous year [5] Group 6: Sales Expenses - Sales expenses increased by 44.04% year-on-year, primarily due to higher water meter testing costs [6] Group 7: Future Development Plans - The company aims to expand its water and environmental services through both organic growth and acquisitions, focusing on integrated water management and exploring new markets [7] - Plans include diversifying into areas such as reclaimed water utilization and waste disposal [7] Group 8: Pricing Mechanism - Water supply prices are adjusted based on national policies and agreements, with periodic reviews and adjustments based on cost changes [8] Group 9: Capital Expenditure and Dividends - The company anticipates a decrease in capital expenditure as new projects come online, which will enhance free cash flow and allow for improved dividend distribution [9]

Group 1: Industry Position and Market Dynamics - The spandex product prices and profit levels are currently at historical lows [2][4] - The industry inventory is around 50 days, while the company's inventory is approximately 20 days [3][4] - The spandex market is expected to see limited price rebound in the short term due to supply-demand factors, but long-term demand is projected to grow steadily [3][4] Group 2: Company Expansion and Production Plans - The company has no new expansion plans beyond the ongoing 150,000-ton spandex project, which is expected to be completed by the end of 2026 [2][3] - The PTMEG project is progressing as per the original plan [3] - The company is focusing on its core polyurethane industry chain development and aims to become a leading global player [3][4] Group 3: Raw Material Procurement and Cost Advantages - The company has significant advantages in raw material procurement due to its large-scale production capacity, enhancing negotiation power with suppliers [3] - The company’s adipic acid production benefits from advanced processes that improve material efficiency and reduce costs [3] Group 4: Financial Strategy and Shareholder Returns - The company maintains a cash-rich position and is committed to a balanced approach to investments and dividends, considering both short-term and long-term shareholder interests [3][4] - A structured plan for shareholder returns is being developed, focusing on sustainable and stable returns [3] Group 5: Market Demand and Product Structure - The demand for polyurethane raw materials remains stable, with applications in various industries such as footwear and furniture [3] - Approximately 25% of the company's spandex products are differentiated products, catering to various market segments [3]